Skip to content
GLP-1 Scorecard
Menu
Site position #33

Peter MD

By GLP-1 ScorecardUpdated

Peter MD advertises B12 injection packages with consultations, supplies and shipping, but its public price displays differ and the ongoing GLP-1 charge needs a written quote.

Our take

Peter MD is worth a quote request for its bundled B12 injection offers, but we would not choose a longer commitment from its $149 headlines. Main-site prices differ, the tirzepatide renewal is unstated, and the care assignment and refund questions need answers before payment.

Visit Peter MDWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
From $149/month advertised with B12; other page prices differ; confirm charge and renewal
Tirzepatide
From $149/month with B12; $100 off first month advertised; renewal unconfirmed
Coverage
Confirm availability for the specific GLP-1 prescription and shipping state
Brand-name
Not confirmed

Weigh Peter MD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Dedicated pages advertise semaglutide+B12 and tirzepatide+B12 from $149 per month; tirzepatide also advertises $100 off the first month. These do not establish the renewal charge. Main-site price displays differ.

Start with the offer, not the account

Peter MD is worth comparing for someone considering compounded GLP-1 injections who wants consultations, supplies and delivery in one advertised package. Its dedicated semaglutide and tirzepatide pages both start at $149 per month and describe B12 formulations. That is enough to begin comparing a service, but not enough to authorize a long commitment. The main-site offers display different prices and do not settle the same contract.

Our recommendation is to obtain one written quote naming the preparation, quantity, initial charge and next payment before deciding. A platform offering several treatment categories can be convenient, but that convenience should come after a satisfactory GLP-1 care and payment arrangement. We would pass if support cannot explain which public offer applies.

Semaglutide has several public price displays

The dedicated semaglutide page advertises compounded semaglutide with B12 starting at $149 per month. Its comparison gives $447 as an average 90-day plan cost. That comparison is not a selected purchase showing your initial debit, prescription quantity or recurring interval. It also does not establish a lower returning-patient rate.

The main GLP1+B12 page instead shows a three-month, 90-day-supply block at $315, with $358 as the regular price. Adjacent wording refers to TRT, which makes the offer harder to interpret. An older public GLP-1 subscription listing shows $270 beside a crossed-out $417 without establishing the formulation or billing interval. Do not treat that older display as a current patient quote. These displays should be reconciled with Peter MD rather than collapsed into one monthly price.

The tirzepatide discount does not establish the renewal

The dedicated tirzepatide page advertises tirzepatide mixed with B12 starting at $149 per month and $100 off the first month. It does not state the subsequent charge or whole first-quarter payment. We would not turn those two advertising numbers into a confirmed $249 renewal. Ask for the next amount and processing date in writing.

The same quote should specify concentration, vial contents, prescribed dose and usable duration. The readable offers do not settle those details, and a vial’s total milligrams would not itself describe an administered dose. Someone shopping for a specific oral preparation or branded product should ask about that separately; the B12 injection offers do not establish an oral or branded option or its price.

Included consultations do not make labs free

Both dedicated offers advertise unlimited consultations, supplies, shipping, membership and app access. Laboratory testing is advertised at 50% off, rather than included without charge. Ask for the undiscounted testing price and which initial or follow-up tests your prescriber requires before treating the headline as a complete budget.

The main GLP1 page describes hormone testing, results in five to seven business days and repeat testing at 90 days. That hormone-focused block sits alongside TRT language; it does not establish the monitoring schedule for a GLP-1 prescription. The useful question is what care your proposed treatment requires, who reviews results and how to reach the clinician between appointments.

Know who treats you and which states the product serves

The dedicated pages describe purchasing a program before onboarding and consultation. Their 24-hour contact and scheduling statements are service expectations, not a guarantee of a completed visit or prescription. Before paying, ask what happens if a clinician declines treatment and whether a live appointment is available when needed.

The terms identify PeterMD at a Vero Beach contact address. The About page names Bryan Henry as President of Peter Holdings and lists Kirk Parsley and Carrie Carda as advisory figures. Those disclosures do not identify your assigned prescriber or the medical practice contracting for your care. Request those details and the clinician’s authorization to treat you in your state.

We did not establish a complete current product-specific state map. Confirm that the exact prescription can be provided to your shipping address, including the treating clinician and dispensing pharmacy.

Named pharmacies are not a dispensing assignment

The terms name Absolute Pharmacy at the Lutz, Florida address and Partell Pharmacy at a Las Vegas address. They also discuss sending a prescription to a patient-chosen pharmacy. These are starting points for a pharmacy question, not confirmation of who fills your particular prescription or whether another pharmacy preserves the advertised package price.

The matching Lutz location appears in Oklahoma’s board record for Absolute Pharmacy, LLC, nonresident permit 99-10292, in good standing through September 30, 2027, replacing 99-6764. The record’s Sterile Compounding field says No. That narrow state record does not establish sterile-compounding capacity, nationwide permission or assignment to a Peter MD order. Ask for the actual dispensing location rather than treating a named pharmacy as a blanket assurance.

Cancellation needs a date, not just an anytime promise

The auto-bill policy applies automatic renewal to select products at intervals described during purchase. It requires an email cancellation at least 48 hours before renewal processing and refuses cancellation inside that window. A generic cancel-anytime statement therefore should not be read as permission to stop a payment immediately before it runs.

Get the exact renewal date, interval and cancellation address with the quote, and retain the response. The public policy does not settle which recurring schedule governs the GLP-1 offer you saw, or what becomes of an unused prepaid balance. Until those points are clear, we would compare a shorter commitment rather than calculate an assumed six-month saving.

Treat the refund policy as a purchase decision

The refund policy makes sales final once medication is received, including unused medication. For damage or defects, it describes replacement after an email, photograph and proof of purchase within 24 hours of receipt. A later paragraph mentions refund exceptions for defects, so the wording should not be treated as an unconditional cash-refund promise.

Before purchasing, ask separately about clinical rejection and cancellation before dispatch; the received-medication rule does not resolve those situations. Peter MD may suit someone who gets a clear B12-injection quote and accepts the documented cancellation and refund limits. It is a weaker fit for someone who needs a settled recurring budget or a refundable trial before choosing care. The deciding advantage should be a clear treatment arrangement, not the lowest number on one page.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value80/100
Dose & formulation82/100
Clinical oversight80/100
Labs & monitoring74/100
Fulfillment78/100
Contract terms66/100

Strengths

  • Dedicated offers advertise consultations, supplies, shipping and membership together
  • Public pages name pharmacy possibilities and disclose an email cancellation window
  • Laboratory testing is advertised at 50% off

What to consider

  • Starting prices do not establish the renewal; main-site price displays differ
  • Specific GLP-1 state eligibility, assigned clinician and dispensing pharmacy remain unconfirmed
  • Labs are discounted rather than free; GLP-1-specific monitoring and total testing cost remain unclear
  • Auto-renewal cancellation requires at least 48 hours’ email notice; sales are final once medication is received
  • Clinical rejection and unused-prepayment refund terms remain unresolved

Bottom line — Grade C+

Best for: People considering clinician-prescribed compounded injections who value advertised consultations, supplies and delivery together, and will confirm the exact product and payment schedule before paying.

Look elsewhere if: People who need a confirmed ongoing price, a specific oral or branded offer, or a clearly refundable trial before selecting a service.

Site position #33 of 540. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Peter MD — the realistic shortlist.

The 19 rankings nearest this one

View full scorecard rankings →

Prices and terms can change; confirm them with Peter MD. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard